US biopharma company Incyte bags Opzelura FDA approval for vitiligo
Opzelura FDA approval for vitiligo : Incyte has secured approval for Opzelura (ruxolitinib) cream 1.5% from the US Food and Drug Administration (FDA) for the ... Read More
Fenix Resources takes full ownership of haulage transport business
Fenix Resources, an Australian iron ore producer, has taken full ownership of Fenix-Newhaul by closing the previously announced acquisition of the remaining 50% stake in ... Read More
Cargill, Continental Grain close $4.5bn acquisition of Sanderson Farms
Cargill and Continental Grain Company have wrapped up the previously announced joint $4.53 billion acquisition of Sanderson Farms, an American poultry company that was listed ... Read More
Marks and Spencer to acquire contract logistics provider Gist Limited
British retailer Marks and Spencer Group has agreed to acquire Gist Limited, a contract logistics business, from Storeshield Limited, a subsidiary of The BOC Group, ... Read More
Toyoda Gosei begins production at Miyagi Ohira Plant
Toyoda Gosei said that its subsidiary Toyoda Gosei East Japan has commenced production of large plastic automotive parts at its Miyagi Ohira Plant in Miyagi, ... Read More
SMS Pharmaceuticals gets EDQM’s CEP approval for Ibuprofen
SMS Pharmaceuticals Limited said that it has secured certificate of suitability (CEP) approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM) ... Read More
Hindustan Unilever opens detergent powder factory in Sumerpur, UP
Hindustan Unilever Limited has inaugurated a new spray dried detergent powder factory and an automated distribution centre in Sumerpur, Uttar Pradesh (UP) of its subsidiary ... Read More
Granules India reports FDA made six observations at Chantilly plant
Granules India Limited said that the US Food and Drug Administration (FDA) has carried out an inspection of its pharmaceutical manufacturing facility in Chantilly, Virginia, ... Read More
Neuraptive Therapeutics begins patient enrollment in NTX-001 facial paralysis trial
Neuraptive Therapeutics said that it has enrolled the first patient in its phase 2a clinical trial of NTX-001 for the treatment and prevention of facial ... Read More
CANbridge Pharmaceuticals begins CAN103 phase 1/2 trial in Gaucher disease
CANbridge Pharmaceuticals said that it has dosed the first patient in a phase 1/2 trial of CAN103 in treatment-naïve patients in China having Gaucher disease ... Read More